Japan’s FY2024 pharmaceutical sales revealed a sharp divergence among immune checkpoint inhibitors as MSD’s Keytruda (pembrolizumab) surged toward the 200-billion-yen…
HOME > REGULATORY
REGULATORY
- FSA to Determine Whether Infertility Treatment Should Be Covered by Private Insurers
October 19, 2012
- PAFSC’s Second Committee to Review Additional Indication for Afinitor on Oct. 31
October 19, 2012
- PAFSC Committee Recommends Approval for Switch OTC Version of Epadel 2 Years after Frist Review
October 18, 2012
- MHLW’s FY2013 Budget Request Seeks More Funding Aimed at Reducing the Drug Lag Based on Results of Policy Evaluation
October 18, 2012
- MHLW to Compile New Generic Share Goal, Roadmap within FY2012
October 17, 2012
- Generic Substitution Could Save 1.53 Trillion Yen in Healthcare Spending: MOF
October 17, 2012
- Former Health Minister Nagatsuma to Take Over as Chairman of Lower House Committee on Health, Labor and Welfare
October 17, 2012
- Mochida’s Epadel Hastily Added to Review List for PAFSC’s Committee on Non-Prescription Drugs
October 16, 2012
- Gov’t, Municipalities Aim to Conclude Discussions on Funding for 3 Add’l Vaccines by Year End
October 16, 2012
- PAFSC’s 1st Committee to Review 4 Products Including Pfizer’s Toviaz on Oct. 26
October 15, 2012
- MEXT Requests Budget for Boosting Number of Pharmacists, Promoting Generic Use at National University Hospitals
October 15, 2012
- Trilateral Meeting of Health Ministers to Be Postponed After China Cites Inability to Attend
October 15, 2012
- MHLW to Begin Pilot Study on Drug Risk Management Plans for Generics
October 12, 2012
- Discussions on Cost-Effective Assessments Are for Preserving National Health Insurance System: Parliamentary Secretary Umemura
October 11, 2012
- Results of Paper-Based Inspection of Japan’s Application for Membership in PIC/S to Be Reported Next May
October 10, 2012
- Dr Takenaka Tapped as NIBIO Advisor, Committed to Creation of Drug Discovery Network
October 9, 2012
- Senior Vice Minister of Health Sakurai Stresses Need to Rebuild Ties with JMA
October 9, 2012
- Health Minister Mitsui Hopes to Ban All Forms of Dispensing Point Services Including Those Using Credit Cards
October 9, 2012
- MHLW to Request Development of 5 Drugs/Indications Determined to Have Unmet Medical Needs
October 5, 2012
- Ministry-Wide Discussions on Generics Necessary: Parliamentary Secretary Umemura
October 4, 2012
ページ
I recently attended a fantastic conference hosted by Prospection Japan, and one speaker, Dr. Joe Ledsam, really blew me away with his insights. He shared some truly fascinating developments about how AI is set to revolutionize healthcare, from how doctors…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…